abstract |
Compounds of the formula I: <IMAGE> or a pharmaceutically acceptable salt thereof, wherein R<1>, R<2>, R<3>, R<4>, R<5>, A<1>, A<2>, A<3> and X<2>, are as defined in the specification, together with pharmaceutical compositions for treatment of interleukin-1 mediated disorders or diseases comprising the compounds, are disclosed. |